Pharmacy compounding veteran A.J. Day becomes CEO of Wilcrest Pharma

Posted on by

Newly formed, Houston-based 503B outsourcing facility will manufacture medications to meet demand for antineoplastic drugs and alleviate drug shortages. HOUSTON, Sept. 6, 2024 /PRNewswire/ — Wilcrest Pharma, a newly formed, Houston-based 503B outsourcing facility specializing in…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.